Dr. Brenda Louise Gallie currently directs the Retinoblastoma Program at the Hospital for Sick Children. After completing her medical training, Dr. Gallie joined Sick Kids Hospital where she set up a Retinoblastoma Group and laboratory in Toronto, which led to the discovery of new therapies for retinoblastoma, as well as novel discoveries in cancer research.  By 2006, she led a National Strategy to develop the world’s first guidelines for care for retinoblastoma. Furthermore, to address the global disparity of cancer care and outcomes, she developed point-of-care cancer site-specific databases, now supporting global collaboration and treatment guidelines. Dr. Gallie has been named member of the Order of Canada in recognition of her pioneering research, as well as achieved the Helen Keller Prize for Vision Research.

Dr. Wilson is the Barrett G Haik Endowed Chair and Professor of Ophthalmology at the University of Tennessee Health Sciences Center, and Director of the Hamilton Eye Institute. He is also Chief of Ophthalmology at St Jude Children’s Research Hospital and holds their Endowed Chair in Pediatric Ophthalmology. Dr. Wilson has active clinical and translational research programs; he has published over 140 peer-reviewed manuscripts. He has also chaired multiple education committees for the American Academy of Ophthalmology. Dr. Wilson has worked extensively with the Department of Pediatric Global at St. Jude Children’s Research Hospital to build retinoblastoma centers of excellence in Central America, the Middle East, Southeast Asia, and Sub-Saharan Africa. Dr. Wilson has trained numerous Fellows in both ocular oncology and oculoplastics.

After undergraduate and ophthalmology studies at the University of Nairobi, Ciku worked as a Provincial Ophthalmologist in Nakuru, Kenya before relocating to Rwanda. She is the Co-Founder of the  Rwanda International Institute of Ophthalmology (RIIO). She has an MSc in Community Ophthalmology from University College London and studied retinal diseases in African eyes for her PHD at the London School of Hygiene and Tropical Medicine.

Ciku is the Medical Advisor for Africa at Orbis International (previously Fred Hollows Foundation).   She sat on the Board of the International Council of Ophthalmology (ICO) from 2013 to 2021 and currently sits on the board of Ophthalmology Foundation and Fred Hollows Foundation, Kenya. She is a professor of ophthalmology and consultant ophthalmologist with medical retina subspecialty. She has also worked extensively on WHO Technical Committees notably in developing the Primary Eye Care curriculum for the African region. In 2021 she was awarded the IAPB Vision Excellence award and was on the Ophthalmology Power List of the 100 most influential women in Ophthalmology. In January 2023 Ciku became the President of the African Ophthalmology Council.

After medical studies and residency in Lausanne, Francis Munier obtained board certification in both Ophthalmology and Medical Genetics. From 1991 to 1993, he received additional training at Children’s Hospital Los-Angeles with Linn-Murphree.

His team contributed to extend the frontiers of conservative management, notably by introducing techniques for intravitreal and intracameral chemotherapy.

In 2015, he was appointed Full Professor and Head of Ocular Oncology, Pathology & Genetics at Jules-Gonin Eye Hospital. He was elected honorary secretary of ISOO in 2017 and president of ISGEDR in 2019. Today the Lausanne Retinoblastoma Clinic has become a quaternary reference center, recruiting 50-60 new patients yearly from 75 nations.

Dr. Carol Shields completed her ophthalmology training at Wills Eye Hospital in Philadelphia and fellowship training in ocular oncology and ophthalmic pathology. She is Director of the Oncology Service, Wills Eye Hospital, and Professor of Ophthalmology at Thomas Jefferson University in Philadelphia, PA USA.

She has authored/coauthored 12 textbooks, 341 chapters in edited textbooks, over 2000 articles in major peer-reviewed journals, and given nearly 1000 lectureships with 74 named lectures.  The 7 most prestigious awards that have honored her include:

• The American Academy of Ophthalmology Life Achievement Honor Award (2011) for contributions to the field of ophthalmology.
• Induction into the Academic All-American Hall of Fame (2011) for lifetime success in athletics and career.
• President of the International Society of Ocular Oncology (2013-2015) – the largest international society of ocular oncology.
• Ophthalmology Power List 2014, 2016, 2018, 2020 – Nominated by peers as one of the top 100 leaders in the field.  In 2020, Dr. Carol Shields was listed at #1 in the Ophthalmology Power List.
• The Donders Award (2003) – given by the Netherlands Ophthalmological Society every 5 years.  She was the first woman to receive this award.
• America’s Best Eye Doctors [July 21, 2021]- Nominated by Newsweek magazine with an overall rank #7 of all ophthalmologists and rank #1 of all female ophthalmologists.
• Theodore Roosevelt Award – the highest honor the National Collegiate Athletic Association (NCAA) confers on an individual who earned a varsity letter for sports in college and who became a distinguished citizen of national reputation.

Each year the Oncology Service manages over 500 patients with uveal melanoma or retinoblastoma, and hundreds of other intraocular, orbital, and conjunctival tumors from the United States and abroad. She and her husband are the proud parents of 7 children, ranging in age from 22 to 34 years.